Tackling the pillars of ageing to fight COVID-19
- PMID: 33821251
- PMCID: PMC8012026
- DOI: 10.1016/S2666-7568(21)00053-2
Tackling the pillars of ageing to fight COVID-19
Conflict of interest statement
AC discloses the following conflicts of interest: advisory board membership of Eli Lilly; consultancy with Roche Diagnostics, Eli Lilly, and Theras; lectures with Berlin Chemie, Eli Lilly, Novo Nordisk, and Roche Diagnostics; and a research grant with Mitsubishi. FP reports lecture fees from Berlin Chemie, outside the submitted work. All other authors declare no competing interests. This work has been supported by the Italian Ministry of Health—Ricerca Corrente to IRCCS MultiMedica.
Comment on
-
Metformin and risk of mortality in patients hospitalised with COVID-19: a retrospective cohort analysis.Lancet Healthy Longev. 2021 Jan;2(1):e34-e41. doi: 10.1016/S2666-7568(20)30033-7. Epub 2020 Dec 3. Lancet Healthy Longev. 2021. PMID: 33521772 Free PMC article.
References
-
- Campbell JM, Bellman SM, Stephenson MD, Lisy K. Metformin reduces all-cause mortality and diseases of ageing independent of its effect on diabetes control: a systematic review and meta-analysis. Ageing Res Rev. 2017;40:31–44. - PubMed
-
- American Federation for Aging Research The TAME trial. Targeting the biology of aging. Ushering a new era of interventions. 2021. https://www.afar.org/tame-trial
-
- Prattichizzo F, Giuliani A, Mensà E. Pleiotropic effects of metformin: shaping the microbiome to manage type 2 diabetes and postpone ageing. Ageing Res Rev. 2018;48:87–98. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
